ETC
TEVA icon

Exchange Traded Concepts’s Teva Pharmaceuticals TEVA Stock Holding History

Exchange Traded Concepts’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
45,551
+9,759
+27% +$325K 0.01% 798
2026
Q1 		$1.08M Buy
35,792
+9,568
+36% +$308K 0.01% 783
2025
Q4 		$818K Buy
+26,224
New +$646K 0.01% 891

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Exchange Traded Concepts's TEVA Position: Q2 2026 in Review

Exchange Traded Concepts increased its Teva Pharmaceuticals (TEVA) stake by 27% in Q2 2026, buying an estimated $325K and bringing the position to 45,551 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #798.

Exchange Traded Concepts first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Exchange Traded Concepts held 45,551 shares of Teva Pharmaceuticals worth $1.54M as of Q2 2026.
  • Exchange Traded Concepts bought 9,759 Teva Pharmaceuticals shares in Q2 2026, an estimated $325K.
  • Teva Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #798 holding.
  • Exchange Traded Concepts first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.